Premium
Cover Picture: Histone‐Deacetylase‐Targeted Fluorescent Ruthenium(II) Polypyridyl Complexes as Potent Anticancer Agents (Chem. Eur. J. 31/2013)
Author(s) -
Ye RuiRong,
Ke ZhuoFeng,
Tan CaiPing,
He Liang,
Ji LiangNian,
Mao ZongWan
Publication year - 2013
Publication title -
chemistry – a european journal
Language(s) - English
Resource type - Reports
SCImago Journal Rank - 1.687
H-Index - 242
eISSN - 1521-3765
pISSN - 0947-6539
DOI - 10.1002/chem.201390113
Subject(s) - ruthenium , histone deacetylase , chemistry , fluorescence , apoptosis , acetylation , histone , cancer research , biochemistry , biology , dna , catalysis , physics , quantum mechanics , gene
Fluorescent ruthenium complexes have been used as inhibitors of histone deacetylases (HDACs). In their Full Paper on page 10160 ff. , Z.‐W Mao, C.‐P. Tan, and co‐workers report a series of red fluorescent ruthenium(II) complexes that can inhibit HDAC and induce apoptotic cell death in tumor cells. These fluorescent Ru II ‐HDACi conjugates represent a promising class of anticancer agents for potential dual imaging and therapeutic applications targeting HDACs (cover graphic by Mu‐Qiang Wei).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom